Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01353495 · ClinicalTrials.gov registry record · NA
Acellular Porcine Dermal Matrix Wound Dressing in the Management of Diabetic Foot Ulcers
A NA study, sponsored by Stryker Trauma and Extremities.
- Completed
- Registry status
- NA
- Development phase
- 39
- Enrollment target
NCT01353495 is a NA study that has completed, run by Stryker Trauma and Extremities. The registered enrollment target is 39 participants.
The verdict
NCT01353495, a NA study, has completed, sponsored by Stryker Trauma and Extremities.
- COMPLETED
- Registry status
- NA
- Development phase
- 39 participants
- Enrollment target
Study Summary
Have indolent diabetic ulcers completely healed by the Acellular Porcine Dermal Matrix (APM) in 12 weeks.
Interventions
- DEVICE APM Graft (BIOTAPE XMTM)
- OTHER Wound Debridement
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 39 participants |
| Start Date | 2010-04 |
| Est. Completion | 2011-04 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01353495
The ClinicalTrials.gov registry entry for NCT01353495 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 39 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Stryker Trauma and Extremities, which has 30 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which APM Graft (BIOTAPE XMTM) is the first listed.
NCT01353495 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01353495 about?
NCT01353495 is a clinical study titled "Acellular Porcine Dermal Matrix Wound Dressing in the Management of Diabetic Foot Ulcers". Have indolent diabetic ulcers completely healed by the Acellular Porcine Dermal Matrix (APM) in 12 weeks.
What is the current status of trial NCT01353495?
This trial is currently completed. It is a NA study. The enrollment target is 39 participants. The study started on 2010-04. Estimated completion is 2011-04.
What interventions are being tested in trial NCT01353495?
The interventions under investigation include: APM Graft (BIOTAPE XMTM) (DEVICE), Wound Debridement (OTHER).
Who is sponsoring clinical trial NCT01353495?
This trial is sponsored by Stryker Trauma and Extremities, which has 30 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.